"Castleman Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.
| Descriptor ID |
D005871
|
| MeSH Number(s) |
C15.604.515.245 C20.683.515.250
|
| Concept/Terms |
Castleman Disease- Castleman Disease
- Angiofollicular Lymphoid Hyperplasia
- Angiofollicular Lymphoid Hyperplasias
- Hyperplasia, Angiofollicular Lymphoid
- Lymphoid Hyperplasia, Angiofollicular
- Castleman's Disease
- Angiofollicular Lymph Node Hyperplasia
- Hyperplasia, Giant Lymph Node
- Lymph Node Hyperplasia, Giant
- Angiofollicular Lymph Hyperplasia
- Angiofollicular Lymph Hyperplasias
- Hyperplasia, Angiofollicular Lymph
- Lymph Hyperplasia, Angiofollicular
- Castlemans Disease
- Disease, Castlemans
- Giant Lymph Node Hyperplasia
- Castleman's Tumor
- Castleman Tumor
- Castlemans Tumor
- Tumor, Castleman's
|
Below are MeSH descriptors whose meaning is more general than "Castleman Disease".
Below are MeSH descriptors whose meaning is more specific than "Castleman Disease".
This graph shows the total number of publications written about "Castleman Disease" by people in this website by year, and whether "Castleman Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 3 | 0 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 4 | 0 | 4 |
| 2014 | 1 | 1 | 2 |
| 2015 | 5 | 1 | 6 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 2 | 0 | 2 |
| 2019 | 4 | 0 | 4 |
| 2020 | 5 | 0 | 5 |
| 2022 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Castleman Disease" by people in Profiles.
-
Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance. PLoS Pathog. 2024 Jul; 20(7):e1012338.
-
Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study. Leuk Lymphoma. 2022 12; 63(13):3082-3091.
-
Predictive Model for Idiopathic Multicentric Castleman Disease Supporting Treatment Decisions. Oncologist. 2021 01; 26(1):4-6.
-
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. Am J Hematol. 2020 12; 95(12):1553-1561.
-
A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study. Oncologist. 2020 11; 25(11):963-973.
-
Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging. Virchows Arch. 2020 Sep; 477(3):437-444.
-
Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials. Lancet Haematol. 2020 Mar; 7(3):e209-e217.
-
Whole-exome sequencing identifies novel somatic alterations associated with outcomes in idiopathic multicentric Castleman disease. Br J Haematol. 2020 03; 188(5):e64-e67.
-
Reactive lymphadenopathy with concurrent idiopathic plasma cell variant Castleman disease, amyloid deposition and non-caseating granulomas. Pathology. 2019 Dec; 51(7):762-764.
-
Unicentric Castleman disease, hyaline vascular variant, stromal rich, with increased plasma cells and a high level of serum IL-6: Raising the diagnostic and therapeutic issues. Ann Diagn Pathol. 2019 Dec; 43:151398.